Professional Presentations (Selected):
Platform:
2023: Cell-type-specific Regulatory Networks of insulin Resistance. Department of Endocrinology and Metabolism Grand Round, Wake Forest School of Medicine, Winston Salem, North Carolina
2022: An Integrative Multiomic Understanding of Insulin Resistance in Human. Department of Endocrinology and Metabolism Grand Round, Wake Forest School of Medicine, Winston Salem, North Carolina
2020: Defining subtypes of type 2 diabetes and precision medicine. Department of Endocrinology and Metabolism Grand Round, Wake Forest School of Medicine, Winston Salem, North Carolina
2020: Adipose Tissue DNA Methylation and Epigenetic Regulatory Mechanisms of Insulin Resistance and Obesity. A webinar sponsored by Diagenode was presented at the OHSU Inaugural Epigenetics Symposium (https://www.ohsu.edu/epigenetics-consortium/ohsu-inaugural-epigenetics-symposium-virtual) on October 22, 2020 at 12PM PDT (lunchtime sponsored seminar). A recording of which is freely available at the Youtube link: https://youtu.be/dRyEBFNMkBc
2020: Integrative Multiomics Analysis of Glucometabolic Traits, Adipose Tissue DNA Methylation, and Gene Expression Identifies Epigenetic Regulatory Mechanisms of Insulin Resistance and Obesity in African Americans. 80th Annual Scientific Session, American Diabetes Association (Virtual, Session name: Genetics of Type 2 Diabetes and Identifying Targets)
2018: Understanding genetic regulatory mechanisms of insulin resistance. The Sticht Center Conference on Aging, Wake forest school of medicine, Winston-Salem, North Carolina.
2018: Genetically-regulated mechanisms of insulin resistance in adipose tissue. Oral abstract session: Genetics, Adipose Tissue, Obesity, and Type 2 Diabetes. 78th Annual Scientific Session, American Diabetes Association, Orlando, Florida (Received Maya Angelou Center for Health Equity at Wake Forest Baptist Medical Center Support for Travel) Webcast
2017: Defining Genetically Regulated Mechanisms of Insulin Resistance in Humans. 2017-2018 Dean’s Research Symposium Series. Center on Diabetes, Obesity and Metabolism Symposium. Comprehensive Cancer Center, Wake Forest Baptist Medical Center.
2016: Deciphering the Mechanistic Basis of the Genetic Contribution to Type 2 Diabetes Mellitus in Humans. Center on Diabetes, Obesity and Metabolism (CDOM)-seminar Series, Wake forest school of medicine, Winston-Salem, North Carolina, Winston-Salem, North Carolina.
2015: Mapping Expression Quantitative Trait Loci (eQTL) to Identify Insulin Resistance, Obesity and Type 2 Diabetes Genes in African Americans. 65th Annual Meeting, American Society of Human Genetics, Baltimore, MD. (Received Maya Angelou Center for Health Equity at Wake Forest Baptist Medical Center Support for Travel)
2015: eQTL Analysis of Adipose and Muscle in African Americans Identifies Genetic Regulators for Type 2 Diabetes and Obesity-associated Genes. 75th Annual Meeting, American Diabetes Association, Boston, Massachusetts (Received Young Investigator Travel Award from ADA) Webcast
2015:Modulation of Micro RNA and Co-Regulated Target Transcripts in Obesity and Insulin Resistance. The Center for Genomics and Personalized Medicine Research seminar series, Wake forest school of medicine, Winston-Salem, North Carolina, Wake forest school of medicine, Winston-Salem, North Carolina.
2014: Mapping diabetes susceptibility by expression traits in Caucasians and African Americans. Department of Bioinformatics and Systems Biology Research Fellows Seminar. Wake forest school of medicine, Winston-Salem, North Carolina, Wake forest school of medicine, Winston-Salem, North Carolina.
2013: An integrative genomic approach to identify novel mechanisms in human obesity. The 2013-2014 Statistical Genetics, Genetic Epidemiology and Bioinformatics Seminar Series of Center for Public Health Genomics, Wake forest school of medicine, Winston-Salem, North Carolina, Wake forest school of medicine, Winston-Salem, North Carolina.
2013: Understanding Biology of Insulin Resistance From a Pharmacogenomic Study. The 2012-2013 Center for Genomics and Personalized Medicine Research seminar series , Wake forest school of medicine, Winston-Salem, North Carolina, Wake forest school of medicine, Winston-Salem, North Carolina.
2012: Regulators of expression quantitative traits as genetic predisposition factors for obesity, insulin resisitance and Type 2 diabetes. The Sticht Center Conference on Aging, Wake forest school of medicine, Winston-Salem, North Carolina.
2012: Integrative genomic approaches to understand the pathophysiology of obesity and insulin resistance.Nutrition Science/BBDOC Seminar Series, Graduate Center for Nutritional Science, Charles T Wethlington building, University of Kentucky, Lexington, Kentucky.
2011: An integrative genomic approach to identify novel mechanisms in human obesity. Molecular pathology graduate program seminar, RH Dean Biomedical research Building, The piedmont triad research park, Winston-Salem, North Carolina
2011: Understanding early pathophysiology of Type 2 Diabetes in humans by integrating physiological, cell biological, gene expression and genetic association studies. The Center for genomics and personalized medicine research seminars, Internal Medicine-Endocrinology conference room, NRC building, Wake forest school of medicine, Winston-Salem, North Carolina
2007: Genome-wide transcription profiling of transformed lymphocytes from discordant sib-pairs under different in vitro conditions for the identification of genes influencing Type2 Diabetes susceptibility. Research Enhancement Award Program seminar on lipotoxicity and metabolic syndrome, University of Arkansas for Medical Sciences, Center on Aging, Little Rock, Arkansas
2003: Localizing a type 2diabetes susceptibility gene on chromosome 1q21-q24 in Utah Caucasians, 53rd Annual Meeting, American Diabetes Association, New Orleans, LA, USA
Poster:
2024: Metaboepigenetic Regulation of Gene Expression in Obesity and Insulin Resistance. Diabetes 2024; 73 (Supplement_1):1673-P. https://doi.org/10.2337/db24-1673-P American Diabetes Association, 84th Annual Scientific Session. Orlando, FL.
2023: A comparison of the obesity-associated transcriptome in skeletal muscle of African Americans and Europeans. American Society of Human genetics Annual Meeting (PB1304, Washington DC, November 2023, Complex Traits and Polygenic Disorders Poster Session II abstract)
2023: Obesity and insulin resistance-associated plasma metabolites may be involved in the epigenetic regulation of gene expression in adipose tissue by modulating DNA methylation levels. The North Carolina Diabetes Research Center, Annual Symposium; September 29, 2023; Greensboro, NC; Poster #3
2022: Cis-regulatory genetic variants influence distinct expression profiles of adipose and muscle tissue transcripts between African and European ancestry individuals. American Society of Human genetics Annual Meeting (PB2771, Los Angeles 2022, Evolutionary and Population Genetics Accepted poster abstract)
2022: Tobacco smoke-derived metabolites in plasma are associated with cardiometabolic traits, are genetically regulated, and may modulate adipose tissue DNA-methylation in African Americans. American Society of Human genetics Annual Meeting (PB2475. Los Angeles 2022, Epigenetics Accepted poster abstract)
2021: Integrative multiomics analyses reveals link between obesity and insulin resistance-associated plasma metabolites and adipose tissue transcripts in African Americans. American Society of Human genetics Annual Meeting (Virtual Meeting 2021)
2020: Common and Ethnic-Specific Molecular Networks and Drivers of Insulin Resistance in African and European Ancestry Individuals. 80th Annual Meeting, American Diabetes Association (Virtual, Moderated poster session, Session name: Genetics of Diabetes).
2019: Altered DNA-Methylation Modulates Adipose Tissue Gene Expression and Is Associated with Insulin Resistance in African Americans. 79th Annual Meeting, American Diabetes Association, San Francisco, California.
2015: Transcriptional Profiles of Adipose and Muscle Tissue Are Associated with Insulin Sensitivity and Influenced by Genetic Variation in African Americans. 75th Annual Meeting, American Diabetes Association, Boston, Massachusetts (Guided Audio poster presentation)
2010: Type 2 Diabetes (T2D) Associated SNPs Regulate Gene Expression in Subcutaneous Adipose Tissue from Caucasian and African American Subjects, American Diabetes Association. 70th Scientific Sessions, American Diabetes Association, Orlando, Florida (Guided Audio poster presentation)
2010: Transcriptional Mechanisms behind the Differential Response to Saturated and Unsaturated Fatty Acid in HepG2 Cells, American Diabetes Association. 70th Scientific Sessions, American Diabetes Association, Orlando, Florida
2009: Genome Wide Analysis of Acute and Chronic Endoplasmic Reticulum (ER) Stress Identifies Novel Pathways of Adaptation to Lipotoxicity, American Diabetes Association. 69th Scientific Sessions, American Diabetes Association, New Orleans, Louisiana
2009: Analysis of Osteocalcin as a Candidate Gene for Type 2 Diabetes (T2D) and Intermediate Traits in Caucasians and African Americans, American Diabetes Association. 69th Scientific Sessions, American Diabetes Association, New Orleans, Louisiana
2008: Endoplasmic Reticulum Stress Response (ERSR) Is not Reduced with Pioglitazone Treatment in Human Adipose Tissue or Human Hepatocyte HepG2 Cell Lines, American Diabetes Association, 68th Annual scientific conference, American Diabetes Association, San Francisco, CA, USA
2008: Genome-wide transcription profiling identifies genes influencing susceptibility to lipotoxicity and type 2 diabetes (T2DM), The American Society of Human Genetics 2008 Annual Meeting, American Society of Human Genetics, Philadelphia, Pennsylvania
2008: Genotype and tissue specific effects on alternative splicing of the transcription factor-7 like2 (TCF7L2) gene in tissues important to type 2 diabetes (T2DM) pathogenesis, Human Genome Meeting HGM2008, Human Genome Organization(HUGO), Hyderabad, India
2007: Genome-wide transcription profiling of transformed lymphocytes from discordant Sib-pairs under different in-vitro conditions for the identification of genes influencing type2 diabetes, American Diabetes Association, 67th Annual scientific conference, American Diabetes Association, Chicago, IL, USA
2007: Copy number polymorphisms in the type 2 diabetes linked region at 1q22 in diabetic and nondiabetic, Caucasian and African American subjects. American Society of Human Genetics, 57th Annual Meeting, American Society of Human Genetics, San Diego, CA, USA
2007: Aryl hydrocarbon receptor nuclear translocator (ARNT) gene as a positional and functional candidate gene for type 2 diabetes. American Diabetes Association, 67th Annual scientific conference, American Diabetes Association, Chicago, IL, USA
2006: TCF7L2 polymorphisms are associated with type 2 diabetes in US Caucasians. American Society of Human Genetics, 56th Annual Meeting. American Society of Human Genetics, New Orleans, LA, USA
2002: Liver pyruvate kinase polymorphisms are associated with type 2 diabetes in Northern European Caucasians. American Society of Human Genetics, 52nd Annual Meeting, American Society of Human Genetics, Baltimore, MD, USA
1999: Genotype-phenotype interaction in EB-thalassaemia patients from West Bengal.Human Genome Meeting HGM1999, Human Genome Organization, Brisbane, Australia
1998: Hereditary persistence of fetal haemoglobin (HPFH): characterization of mutation from families of WestBengal, Eastern India, Using RFLP-PCR technique. 4th International Symposium on genetics, health and disease, Guru Nanak Dev University, Amritsar, India